Navigation Links
Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
Date:8/19/2007

DANVERS, Mass., Aug. 7 /PRNewswire/ -- The results of a pilot study published in the Nutrition Journal (http://www.nutritionj.com) suggest that children with attention deficit hyperactivity disorder (ADHD) can benefit from daily supplementation of high levels of purified fish oils. The eight-week study demonstrated that children who consumed between 8 and 16 grams per day of EPA and DHA (the long chain omega-3 fatty acids found in fish oil) showed significant improvements in their behavior rated by both their parents and the psychiatrist working with them.

The study monitored the ratio of two fatty acids in the blood: arachidonic acid (AA) and eicosapentaenoic acid (EPA). It has been known from previous studies that children with ADHD have a high AA/EPA ratio in the blood compared to control children. The amount of purified fish oil for each child was adjusted until his or her AA/EPA ratio reached ideal levels.

The study found a statistically significant improvement in inattention, hyperactivity, oppositional/defiant behavior and conduct disorders as the AA/EPA ratio in the blood was lowered. The findings were true for children taking their optimal dosage of drugs to manage their ADHD as well for the children who had voluntarily stopped taking their drugs during the study.

"This is an important study as it indicates when adequate levels of fish oil are added to the diet, significant behavioral changes can occur. This study also indicates that the growing epidemic of ADHD may have a strong nutritional component-the lack of sufficient intake of omega-3 fatty acids, such as EPA and DHA," said Dr. Barry Sears, one of the co-authors of the study. "Equally important is that supplementation with high-dose fish oil is synergistic with existing drugs, giving both the physician and parent new dietary approaches toward correcting this growing epidemic in our children."

About ADHD

ADHD is a neurological condition characterized by the inability to concentrate in a sustained manner, to pay attention to tasks, and to control impulsive actions. It is estimated that 3 to 7 percent of children have this disorder. For 60-80 percent of children with ADHD, the condition continues into adulthood.

About Dr. Sears

Dr. Barry Sears is one of the leading experts in the world in use of high- dose omega-3 fatty acids in the treatment of chronic disease conditions. He is the author of the New York Times #1 bestseller The Zone as well as 11 other books on his hormonal control technology, including The OmegaRx Zone and The Anti-Inflammation Zone. His books have sold more than 5 million copies in the United States and have been translated into 22 languages. He is the president of the Inflammation Research Foundation, a non-profit medical research organization that does clinical research in the areas of obesity, diabetes, heart disease, cancer, and neurological disorders.


'/>"/>
SOURCE Zone Labs, Inc.

Copyright©2007 PR Newswire.

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... April 18, 2017 Research and Markets has ... report to their offering. ... The global arthroscopy devices market to grow at a CAGR of ... Arthroscopy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology:
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... Creator responds to and which He does not. Yisrayl says with so many titles ... the true name, but he says with a little Scripture, backed with a lot of ...
(Date:4/28/2017)... ... 28, 2017 , ... NuevaCare, a leading home care agency based in San ... Alto, is proud to announce information upgrades to its blog in the form of ... on topics such as home care (generally) as well as senior care and home ...
(Date:4/27/2017)... ... 2017 , ... The Incentive Research Foundation is pleased to ... a groundbreaking analysis of how behavioral economics can be applied to the incentive, ... programs, the report highlights proven behavioral economics approaches and the powerful role emotions ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, Inc. ... at MobileIron Live! 2017 in Santa Clara, California. Each year, MobileIron ... approach to helping organizations maximize the benefits of mobility in their operations securely. ...
Breaking Medicine News(10 mins):